Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Filings indexed 2,819 across all filing types
Latest filing 2022-08-22 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 1% confidence The document is a company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, total values, and the updated treasury share count. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2022-08-22 Danish
6-K
Foreign Filer Report
2022-08-17 English
Director's Dealing 2022
Director's Dealing Classification · 1% confidence The document explicitly details 'Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons' and references 'Article 19 of Regulation No. 596/2014 on Market Abuse'. This type of filing, which reports personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing. The filing type code for Director's Dealing is DIRS.
2022-08-17 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 1% confidence The document is titled 'Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons'. It explicitly references Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which governs the disclosure of transactions by persons discharging managerial responsibilities (PDMRs). This is a standard notification of insider trading/director dealings. While the document mentions an attachment, the text itself serves as the official announcement of these specific transactions, fitting the 'Director's Dealing' category.
2022-08-17 Danish
6-K
Foreign Filer Report
2022-08-17 English
6-K
Foreign Filer Report
2022-08-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.